Filing Details

Accession Number:
0001447028-20-000152
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-16 16:33:56
Reporting Period:
2020-12-14
Accepted Time:
2020-12-16 16:33:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447028 Arbutus Biopharma Corp ABUS Pharmaceutical Preparations (2834) 980597776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635326 J. Michael Mcelhaugh C/O Arbutus Biopharma Corporation
701 Veterans Circle
Warminster PA 18974
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-14 30,000 $5.00 1,337,457 No 4 S Direct
Common Stock Disposition 2020-12-14 10,000 $5.00 1,327,457 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.